A study found that patients who were vaccinated against COVID-19 were more likely to die from the virus than those who were not vaccinated against the virus.
Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial virus (RSV).